Recombinant Human Phenazine Biosynthesis-Like Domain-Containing Protein/PBLD is produced by our E.coli expression system. The target protein is expressed with sequence (Met1-Ala288) of Human PBLD fused with a 6His tag at the N-terminus.
Reinheit
> 95 % as determined by reducing SDS-PAGE.
Sterilität
0.2 μm filtered
Endotoxin-Niveau
Less than 0.1 ng/μg (1 IEU/μg) as determined by LAL test
It is not recommended to reconstitute to a concentration less than 100 μg/mL. Dissolve the lyophilized protein in ddH2O. Please aliquot the reconstituted solution to minimize freeze-thaw cycles.
Buffer
Supplied as a 0.2 μm filtered solution of 20 mM Tris, 100 mM NaCl, 1 mM DTT, 30 % Glycerol, pH 8.0.
Konservierungsmittel
Dithiothreitol (DTT)
Vorsichtsmaßnahmen
This product contains Dithiothreitol (DTT): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handhabung
Always centrifuge tubes before opening. Do not mix by vortex or pipetting.
Lagerung
-80 °C
Informationen zur Lagerung
Store at < -20°C, stable for 6 months after receipt. Please minimize freeze-thaw cycles.
Haltbarkeit
6 months
Target
PBLD1
(Phenazine Biosynthesis-Like Protein Domain Containing 1 (PBLD1))
MAWBP Protein, MAWDBP Protein, 0610038K03Rik Protein, Mawbp Protein, Pbld Protein, phenazine biosynthesis like protein domain containing Protein, phenazine biosynthesis-like protein domain containing 1 Protein, PBLD Protein, Pbld1 Protein
Sub Type
Fusionprotein
Hintergrund
Phenazine Biosynthesis-Like Domain-Containing protein (PBLD) belongs to the phenazine biosynthesis-like protein (PhzF) family, which is expressed in most tissues. PBLD takes part in the MAPK signaling pathway, and is involved in multiple basic cellular functions. The expression of PBLD can be increased in several disease processes, including insulin resistance, folate deficiency and hypotension. Alternative Names: Phenazine Biosynthesis-Like Domain-Containing Protein, MAWD-Binding Protein, MAWDBP, Unknown Protein 32 From 2D-PAGE of Liver Tissue, PBLD, MAWBP